Literature DB >> 25605437

PET-Florbetapir findings in primary cerebral amyloidoma.

Alberto Villarejo-Galende1, Pilar Sarandeses, Marta Penas-Prado, Aurelio Hernández-Laín, Ana Ramos, Ana Cristina Hernández-Martínez, Eva Carro, José Ramón Ricoy, Jesús Hernández-Gallego.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25605437     DOI： 10.1007/s00415-015-7643-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Primary brain amyloidoma: long-term follow-up.

Authors:  Dimitri Renard; Chantal Campello; Valerie Rigau; Nicolas de Champfleur; Pierre Labauge
Journal:  Arch Neurol       Date:  2008-07

Review 2.  Amyloidoma presenting as a butterfly glioma on positron emission tomography scan and magnetic resonance-spectroscopy: a case report and review of the literature.

Authors:  Anthony H Sin; Eduardo Gonzalez-Toledo; Marjorie Fowler; Alireza Minagar; Anil Nanda
Journal:  J La State Med Soc       Date:  2008 Jan-Feb

3.  A 61-year-old man with instability of gait and right hand clumsiness.

Authors:  Anne Vital; Emmanuel Ellie; Hugues Loiseau
Journal:  Brain Pathol       Date:  2010-01       Impact factor: 6.508

4.  Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.

Authors:  Adam S Fleisher; Kewei Chen; Xiaofen Liu; Auttawut Roontiva; Pradeep Thiyyagura; Napatkamon Ayutyanont; Abhinay D Joshi; Christopher M Clark; Mark A Mintun; Michael J Pontecorvo; P Murali Doraiswamy; Keith A Johnson; Daniel M Skovronsky; Eric M Reiman
Journal:  Arch Neurol       Date:  2011-07-11

Review 5.  Intracerebral amyloidoma: case report and review of the literature.

Authors:  H Foreid; C Barroso; T Evangelista; A Campos; J Pimentel
Journal:  Clin Neuropathol       Date:  2010 Jul-Aug       Impact factor: 1.368

6.  Use of florbetapir-PET for imaging beta-amyloid pathology.

Authors:  Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas G Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric P Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

7.  Tumor-like amyloid formation (amyloidoma) in the brain.

Authors:  F W Spaar; H H Goebel; E Volles; J Wickboldt
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

8.  Novel isolated cerebral ALlambda amyloid angiopathy with widespread subcortical distribution and leukoencephalopathy due to atypical monoclonal plasma cell proliferation, and terminal systemic gammopathy.

Authors:  Roland Schröder; Martina Deckert; Reinhold P Linke
Journal:  J Neuropathol Exp Neurol       Date:  2009-03       Impact factor: 3.685
  8 in total
  2 in total

1.  Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds.

Authors:  T Wagner; J Page; M Burniston; A Skillen; J C Ross; R Manwani; D McCool; P N Hawkins; Ashutosh D Wechalekar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-12       Impact factor: 9.236

2.  Cerebral Amyloidoma Accompanied by Sjögren's Syndrome: A Case Report and Literature Review.

Authors:  Haruki Yamashita; Motoaki Fujimoto; Ryuta Yokogawa; Tomoaki Taguchi; Jiro Ohara; Hideki Ogata; Yoshinori Akiyama
Journal:  NMC Case Rep J       Date:  2021-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.